An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Provided herein are novel imidazopyridine and imidazopyridazine derivatives as DGAT2 inhibitors, pharmaceutical compositions, use of such compounds in treating multiple diseases, and processes for preparing such compounds.
The author declares no competing financial interest.
References
Deng B.; Kong W.; Shen X.; Han C.; Zhao Z.; Chen S.; Zhou C.; Bae-Jump V. The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications. J. Transl. Med. 2024, 22, 290. 10.1186/s12967-024-05084-z.
-
DOI
-
PMC
-
PubMed
Wolk M.; Fedorova M. The lipid droplet lipidome. FEBS Lett. 2024, 598, 1215–1225. 10.1002/1873-3468.14874.
-
DOI
-
PubMed
Amin N. B.; Saxena A. R.; Somayaji V.; Dullea R. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology. Clin. Ther. 2023, 45, 55–70. 10.1016/j.clinthera.2022.12.008.
-
DOI
-
PubMed
Sabnis R. W. Benzimidazolone Derivatives as DGAT2 Inhibitors for Treating Diseases. ACS Med. Chem. Lett. 2022, 13, 1004–1005. 10.1021/acsmedchemlett.2c00247.
-
DOI
-
PMC
-
PubMed
Darabi M.; Kontush A. High-density lipoproteins (HDL): Novel function and therapeutic applications. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2022, 1867, 159058. 10.1016/j.bbalip.2021.159058.
-
DOI
-
PubMed